Cargando…
Outcome of acute respiratory distress syndrome requiring extracorporeal membrane oxygenation in Covid‐19 or influenza: A single‐center registry study
Veno‐venous extracorporeal membrane oxygenation (V‐V ECMO) is used to sustain blood oxygenation and decarboxylation in severe acute respiratory distress syndrome (ARDS). It is under debate if V‐V ECMO is as appropriate for coronavirus disease 2019 (Covid‐19) ARDS as it is for influenza. In this retr...
Autores principales: | Jäckel, Markus, Rilinger, Jonathan, Lang, Corinna Nadine, Zotzmann, Viviane, Kaier, Klaus, Stachon, Peter, Biever, Paul Marc, Wengenmayer, Tobias, Duerschmied, Daniel, Bode, Christoph, Staudacher, Dawid Leander, Supady, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753485/ https://www.ncbi.nlm.nih.gov/pubmed/33188714 http://dx.doi.org/10.1111/aor.13865 |
Ejemplares similares
-
Influence of immunosuppression in patients with severe acute respiratory distress syndrome on veno‐venous extracorporeal membrane oxygenation therapy
por: Rilinger, Jonathan, et al.
Publicado: (2021) -
Extracorporeal membrane oxygenation during the first three waves of the coronavirus disease 2019 pandemic—A retrospective single‐center registry study
por: Widmeier, Eugen, et al.
Publicado: (2022) -
Mobile ECMO retrieval of patients during the COVID‐19 pandemic
por: Widmeier, Eugen, et al.
Publicado: (2021) -
Long-term survival and health-related quality of life in patients with severe acute respiratory distress syndrome and veno-venous extracorporeal membrane oxygenation support
por: Rilinger, Jonathan, et al.
Publicado: (2021) -
Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience
por: Zotzmann, Viviane, et al.
Publicado: (2019)